STOCK TITAN
  1. Home
  2. News
  3. OCEA

Ocean Biomedical Inc. - OCEA STOCK NEWS

IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical (NASDAQ: OCEA) Announces Enrollment of Patients for Phase 1b Study for Chronic Hepatitis B Treatment in 50-50 Joint Venture with Virion Therapeutics
clinical trial
IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical and Virion Therapeutics Form Joint Venture Supporting Multi-National, First-In-Humans Clinical Chronic Hepatitis B Study: Now Enrolling, With Goal of a Functional Cure for a Disease Affecting 300+ Million Patients Worldwide
IMPACT
SENTIMENT
OCEA : Nasdaq
Updated: Ocean Biomedical Announces Non-Dilutive Amendment to Existing Agreement with Polar Multi-Strategy Master Fund
IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical Announces Loan Commitment from Largest Stockholder; Up to $10 Million
IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical Announces Non-Dilutive Amendment to Existing Agreement with a Key Financing Partner
IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical Announces Newly Published Findings Demonstrating Ability to Restore Treatment Sensitivity to AstraZeneca’s Leading Lung Cancer Drug After Resistance Has Formed, and Enhanced Tumor Suppression in EGFR-Mutation Lung Cancers
IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical (NASDAQ: OCEA) Will Host an R&D Update Today on Malaria, and Fibrosis Programs with Scientific Co-founders Jack A. Elias, MD, and Jonathan Kurtis, MD PhD.
IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical (NASDAQ: OCEA) Announces New Patent for Anti-Fibrosis Discovery with Allowance in Alcoholic Liver Disease and Multiple Fibrotic Conditions, Leading Causes of Death in the U.S.
IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical (NASDAQ: OCEA) Provides Latest Updates on its Broad Programs in Malaria, Fibrosis, and Multiple Cancers
IMPACT
SENTIMENT
OCEA : Nasdaq
Ocean Biomedical (NASDAQ: OCEA) Share Price Target Now Averaging $18.21, Based on Research and Development Progress in Three Promising Programs Generating Novel Treatment Candidates for Cancer, Malaria, and Fibrosis.
Stock OCEA logo
Ocean Biomedical Inc.
Nasdaq:OCEA

OCEA Stock Data

Research and Development in Biotechnology
Professional, Scientific, and Technical Services